— Signal history
LABT alerts
Every time Stock Pulse flagged LABT in real time — with the full post-mortem behind each alert.
1alert
+62%best run
+62%median peak
-29%worst close
Lakewood-Amedex Biotherapeutics, Inc.
Lakewood-Amedex is a clinical-stage biotech working on Nu-3, an antimicrobial candidate for infected diabetic foot ulcers.
Cap~$6M / float: 283K
Day volume79.5M (319x avg)
Prev close$1.86 → opened $6.49
Short interest13% of float
52-week range$1.66–$98.20 (split-distorted)
Snapshot from the Jul 22, 2026 post-mortem.
